GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
GLAXO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
GlaxoSmithKline Pharmaceuticals has submitted a certificate to the stock exchange as required under SEBI's Depositories and Participants Regulations, 2018. This is a routine regulatory compliance filing related to the company's depository operations and share-related activities. The filing does not involve any financial transaction, corporate action, or material business development. It is part of the periodic or event-based reporting that listed companies are required to submit to maintain compliance with SEBI's depository rules.
This is a routine regulatory filing with no material impact on shareholders or the stock price. It simply reflects the company's adherence to standard SEBI compliance requirements.